Moving towards a Treatable Traits model of care for the management of obstructive airways diseases

被引:39
作者
Agusti, Alvar [1 ,2 ]
Barnes, Neil [3 ,4 ]
Cruz, Alvaro A. [5 ]
Gibson, Peter G. [6 ,7 ]
Heaney, Liam G. [8 ]
Inoue, Hiromasa [9 ]
Leather, David [3 ,4 ]
Martinez, Fernando J. [10 ]
McDonald, Vanessa M. [6 ,7 ]
Oppenheimer, John [11 ]
Papi, Alberto [12 ]
Pavord, Ian D. [13 ,14 ]
Thomas, Mike [15 ]
Walker, Samantha [16 ]
Yates, Louisa [3 ,4 ]
机构
[1] Univ Barcelona, Catedra Salud Resp, Resp Inst, Hosp Clin Barcelona, Barcelona, Spain
[2] CIBERES, Barcelona, Spain
[3] Barts & London Queen Marys Sch Med & Dent, William Harvey Res Inst, London, England
[4] Fundacao ProAR, Salvador, BA, Brazil
[5] Univ Fed Bahia, Salvador, BA, Brazil
[6] Univ Newcastle, Fac Hlth & Med, Prior Res Ctr Hlth Lungs, Callaghan, NSW, Australia
[7] Univ Newcastle, Fac Hlth & Med, Hunter Med Res Inst, Callaghan, NSW, Australia
[8] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Wellcome Wolfson Inst Expt Med, Belfast, Antrim, North Ireland
[9] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Pulm Med, Kagoshima, Japan
[10] New York Presbyterian Weill Cornell Med Ctr, Pulm & Crit Care Med Div, New York, NY USA
[11] Rutgers New Jersey Med Sch, Dept Internal Med, Newark, NJ USA
[12] Univ Ferrara, Dept Translat Med, Resp Med, Ferrara, Italy
[13] Univ Oxford, Nuffield Dept Med, Resp Med Unit, Oxford, England
[14] Univ Oxford, Nuffield Dept Med, NIHR Oxford Resp BRC, Oxford, England
[15] Univ Southampton, Primary Care Res Ctr, Sch Primary Care Populat Sci & Med Educ, Southampton, Hants, England
[16] Asthma UK & British Lung Fdn Partnership, London, England
关键词
Asthma; Biomarkers; COPD; Targeted therapy; RANDOMIZED CONTROLLED-TRIALS; EXHALED NITRIC-OXIDE; PULMONARY-DISEASE; SEVERE ASTHMA; TARGETED THERAPIES; EOSINOPHIL COUNTS; MILD ASTHMA; COPD; EXACERBATIONS; PRODUCTIVITY;
D O I
10.1016/j.rmed.2021.106572
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Asthma and chronic obstructive pulmonary disease (COPD) are two prevalent chronic airways diseases. Both are complex and heterogeneous. Traditionally, clinical guidelines have advocated a stepwise approach to pharmacotherapy of asthma and COPD, but there is increasing realization that both require a more personalized and precise management approach. To this end, a management strategy based on the so-called Treatable Traits has been proposed. Emerging evidence suggests that this model improves relevant outcomes in patients with chronic airway diseases but further research is needed to guide implementation. This review discusses the challenges, opportunities, and hurdles that its implementation will have to face.
引用
收藏
页数:8
相关论文
共 71 条
[21]   Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial [J].
Green, RH ;
Brightling, CE ;
McKenna, S ;
Hargadon, B ;
Parker, D ;
Bradding, P ;
Wardlaw, AJ ;
Pavord, ID .
LANCET, 2002, 360 (9347) :1715-1721
[22]   Asthma impacts on workplace productivity in employed patients who are symptomatic despite background therapy: a multinational survey [J].
Gruffydd-Jones, Kevin ;
Thomas, Mike ;
Roman-Rodriguez, Miguel ;
Infantino, Antonio ;
FitzGerald, J. Mark ;
Pavord, Ian ;
Haddon, Jennifer M. ;
Elsasser, Ulrich ;
Vogelberg, Christian .
JOURNAL OF ASTHMA AND ALLERGY, 2019, 12 :183-193
[23]   COPD 2020 Guidelines - what is new and why? [J].
Gupta, Nitesh ;
Agrawal, Sumita ;
Chakrabarti, Shibdas ;
Ish, Pranav .
ADVANCES IN RESPIRATORY MEDICINE, 2020, 88 (01) :38-40
[24]   Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial [J].
Hardy, Jo ;
Baggott, Christina ;
Fingleton, James ;
Reddel, Helen K. ;
Hancox, Robert J. ;
Harwood, Matire ;
Corin, Andrew ;
Sparks, Jenny ;
Hall, Daniela ;
Sabbagh, Donah ;
Mane, Saras ;
Vohlidkova, Alexandra ;
Martindale, John ;
Williams, Mathew ;
Shirtcliffe, Philippa ;
Holliday, Mark ;
Weatherall, Mark ;
Beasley, Richard .
LANCET, 2019, 394 (10202) :919-928
[25]   Severe asthma treatment: need for characterising patients [J].
Heaney, LG ;
Robinson, DS .
LANCET, 2005, 365 (9463) :974-976
[26]   Predictors of therapy resistant asthma: outcome of a systematic evaluation protocol [J].
Heaney, LG ;
Conway, E ;
Kelly, C ;
Johnston, BT ;
English, C ;
Stevenson, M ;
Gamble, J .
THORAX, 2003, 58 (07) :561-566
[27]   Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial [J].
Heaney, Liam G. ;
Busby, John ;
Hanratty, Catherine E. ;
Djukanovic, Ratko ;
Woodcock, Ashley ;
Walker, Samantha M. ;
Hardman, Timothy C. ;
Arron, Joseph R. ;
Choy, David F. ;
Bradding, Peter ;
Brightling, Christopher E. ;
Chaudhuri, Rekha ;
Cowan, Douglas C. ;
Mansur, Adel H. ;
Fowler, Stephen J. ;
Niven, Robert M. ;
Howarth, Peter H. ;
Lordan, James L. ;
Menzies-Gow, Andrew ;
Harrison, Tim W. ;
Robinson, Douglas S. ;
Holweg, Cecile T. J. ;
Matthews, John G. ;
Pavord, Ian D. .
LANCET RESPIRATORY MEDICINE, 2021, 9 (01) :57-68
[28]   Non-adherence in difficult asthma: time to take it seriously [J].
Heaney, Liam G. ;
Horne, Rob .
THORAX, 2012, 67 (03) :268-270
[29]   Real-life inhaler adherence and technique: Time to get smarter! [J].
Henry, Chrystyn ;
Audibert, Raphaele ;
Keller, Manfred ;
Quaglia, Benjamin ;
Vecellio, Laurent ;
Roche, Nicolas .
RESPIRATORY MEDICINE, 2019, 158 :24-32
[30]   Treatable Traits That Predict Health Status and Treatment Response in Airway Disease [J].
Hiles, Sarah A. ;
Gibson, Peter G. ;
Agusti, Alvar ;
McDonald, Vanessa M. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (03) :1255-+